{"id":"https://openalex.org/W4415900370","doi":"https://doi.org/10.1136/jitc-2025-sitc2025.0092","title":"92 Prognostic value of AI-informed LAG-3 to tumor cell ratio in stage IV metastatic bladder cancer patients treated with multiple lines of immune checkpoint inhibitors","display_name":"92 Prognostic value of AI-informed LAG-3 to tumor cell ratio in stage IV metastatic bladder cancer patients treated with multiple lines of immune checkpoint inhibitors","publication_year":2025,"publication_date":"2025-11-01","ids":{"openalex":"https://openalex.org/W4415900370","doi":"https://doi.org/10.1136/jitc-2025-sitc2025.0092"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2025-sitc2025.0092","doi":"https://doi.org/10.1136/jitc-2025-sitc2025.0092","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2025-sitc2025.0092","pdf_url":"https://jitc.bmj.com/content/13/Suppl_2/A103.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/13/Suppl_2/A103.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Sandeep Manandhar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sandeep Manandhar","raw_affiliation_strings":["Emory University, Atlanta, GA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Emory University, Atlanta, GA, USA","institution_ids":["https://openalex.org/I150468666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5124878652","display_name":"Naoto Tokuyama","orcid":"https://orcid.org/0000-0002-7784-4901","observed_orcids":["https://orcid.org/0000-0002-7784-4901"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Naoto Tokuyama","raw_affiliation_strings":["Emory University, Atlanta, GA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Emory University, Atlanta, GA, USA","institution_ids":["https://openalex.org/I150468666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022604050","display_name":"Tilak Bahadur Pathak","orcid":"https://orcid.org/0000-0002-9738-4172","observed_orcids":["https://orcid.org/0000-0002-9738-4172"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tilak Pathak","raw_affiliation_strings":["Cleveland Clinic Foundation, Cleveland, OH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cleveland Clinic Foundation, Cleveland, OH, USA","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021544531","display_name":"Kamal Hammouda","orcid":"https://orcid.org/0000-0003-1598-4287","observed_orcids":["https://orcid.org/0000-0003-1598-4287"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kamal Hammouda","raw_affiliation_strings":["Emory University, Atlanta, GA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Emory University, Atlanta, GA, USA","institution_ids":["https://openalex.org/I150468666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044873389","display_name":"Paul G. Pavicic","orcid":"https://orcid.org/0000-0002-5772-3192","observed_orcids":["https://orcid.org/0000-0002-5772-3192"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul G Pavicic","raw_affiliation_strings":["Cleveland Clinic Foundation, Cleveland, OH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cleveland Clinic Foundation, Cleveland, OH, USA","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079075086","display_name":"Claudia Marcela Diaz-Montero","orcid":"https://orcid.org/0000-0002-6941-4215","observed_orcids":["https://orcid.org/0000-0002-6941-4215"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C Marcela Diaz-Montero","raw_affiliation_strings":["Cleveland Clinic Foundation, Cleveland, OH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cleveland Clinic Foundation, Cleveland, OH, USA","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017229890","display_name":"Shilpa Gupta","orcid":"https://orcid.org/0000-0002-8775-503X","observed_orcids":["https://orcid.org/0000-0002-8775-503X"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shilpa Gupta","raw_affiliation_strings":["Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5027642699","display_name":"Anant Madabhushi","orcid":"https://orcid.org/0000-0002-5741-0399","observed_orcids":["https://orcid.org/0000-0002-5741-0399"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anant Madabhushi","raw_affiliation_strings":["Emory University, Atlanta, GA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Emory University, Atlanta, GA, USA","institution_ids":["https://openalex.org/I150468666"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A103","last_page":"A104"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9794999957084656,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9794999957084656,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.018799999728798866,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12422","display_name":"Radiomics and Machine Learning in Medical Imaging","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lag-3","display_name":"LAG-3","score":0.9789999723434448},{"id":"https://openalex.org/keywords/metastatic-bladder-cancer","display_name":"metastatic bladder cancer","score":0.8289999961853027},{"id":"https://openalex.org/keywords/urothelial-carcinoma","display_name":"urothelial carcinoma","score":0.9300000071525574},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.9670000076293945},{"id":"https://openalex.org/keywords/t-cell-exhaustion","display_name":"T cell exhaustion","score":0.7940000295639038},{"id":"https://openalex.org/keywords/ai-based-image-analysis","display_name":"artificial intelligence image analysis","score":0.5870000123977661},{"id":"https://openalex.org/keywords/hyperprogression","display_name":"hyperprogression","score":0.7699999809265137},{"id":"https://openalex.org/keywords/durvalumab","display_name":"durvalumab","score":0.8180000185966492},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/atezolizumab","display_name":"atezolizumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/pd-1-pd-l1-axis","display_name":"PD-1/PD-L1 axis","score":0.8489999771118164},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.875},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.6140000224113464}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7860000133514404},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5878999829292297},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5314000248908997},{"id":"https://openalex.org/C2776291640","wikidata":"https://www.wikidata.org/wiki/Q2912517","display_name":"Value (mathematics)","level":2,"score":0.4668999910354614},{"id":"https://openalex.org/C2780352672","wikidata":"https://www.wikidata.org/wiki/Q504775","display_name":"Bladder cancer","level":3,"score":0.44859999418258667},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.41749998927116394},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.3788999915122986},{"id":"https://openalex.org/C3020616263","wikidata":"https://www.wikidata.org/wiki/Q1216998","display_name":"Tumor cells","level":2,"score":0.3644999861717224},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.335099995136261},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.3303000032901764},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.31859999895095825},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.3131999969482422},{"id":"https://openalex.org/C2780283643","wikidata":"https://www.wikidata.org/wiki/Q2110267","display_name":"Primary tumor","level":4,"score":0.2962000072002411},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.29499998688697815},{"id":"https://openalex.org/C2992225637","wikidata":"https://www.wikidata.org/wiki/Q504775","display_name":"Bladder tumor","level":4,"score":0.28349998593330383},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.26159998774528503},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.25699999928474426}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/jitc-2025-sitc2025.0092","doi":"https://doi.org/10.1136/jitc-2025-sitc2025.0092","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2025-sitc2025.0092","pdf_url":"https://jitc.bmj.com/content/13/Suppl_2/A103.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2025-sitc2025.0092","doi":"https://doi.org/10.1136/jitc-2025-sitc2025.0092","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2025-sitc2025.0092","pdf_url":"https://jitc.bmj.com/content/13/Suppl_2/A103.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4415900370.pdf","grobid_xml":"https://content.openalex.org/works/W4415900370.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4400108794","https://openalex.org/W4360606295","https://openalex.org/W4386437771","https://openalex.org/W4360605917","https://openalex.org/W3035420485","https://openalex.org/W4319600802","https://openalex.org/W4390937872","https://openalex.org/W4327604759","https://openalex.org/W4400965455","https://openalex.org/W4409634289"],"abstract_inverted_index":{"Background":[0],"Lymphocyte":[1],"activation":[2],"gene-3":[3],"(LAG-3)":[4],"is":[5,381],"an":[6,47,115],"inhibitory":[7],"checkpoint":[8,22],"receptor":[9],"upregulated":[10],"on":[11,377],"chronically":[12],"stimulated":[13],"(\u2018exhausted\u2019)":[14],"T-cells":[15],"within":[16],"the":[17,26,56,160,229,327,340,363,415],"tumor":[18,64,101,122,130,195,300,342,453,481],"microenvironment.":[19],"Although":[20],"immune":[21,61],"inhibitors":[23],"(ICIs)":[24],"targeting":[25],"PD-1/PD-L1":[27,360],"axis":[28],"prolong":[29],"survival":[30,72,76],"in":[31,78,228,354,395,429,442],"metastatic":[32,81,355],"urothelial":[33,82,356],"carcinoma,":[34],"their":[35],"efficacy":[36],"may":[37],"be":[38],"limited":[39],"by":[40,112,147,168,345,421,456,485],"persistent":[41],"LAG-3-mediated":[42],"T-cell":[43],"exhaustion.":[44],"We":[45,126],"applied":[46],"AI-driven":[48,337],"quantitative":[49],"multiplex":[50],"immunofluorescence":[51],"(QMiF)":[52],"pipeline":[53,117],"to":[54,63,452],"calculate":[55],"ratio":[57,197,214,226,264,301,344,483],"of":[58,89,249,253,323,339,383,385,450,479],"LAG-3":[59,119,193],"+":[60,120],"cells":[62,65,123,418],"and":[66,74,108,114,121,138,154,164,170,185,209,231,280,308,367,375,390,400,411,426,460],"assessed":[67,167],"its":[68],"association":[69],"with":[70,86,174,267,359,397],"progression-free":[71],"(PFS)":[73],"overall":[75],"(OS)":[77],"stage":[79],"IV":[80],"cancer":[83],"patients":[84,255],"treated":[85,358],"multiple":[87],"lines":[88],"immunotherapy":[90],"(durvalumab,":[91],"pembrolizumab,":[92],"atezolizumab).Methods":[93],"In":[94,258,289],"our":[95,422],"single-center":[96,368],"retrospective":[97],"cohort":[98],"(n=57),":[99],"primary":[100],"biopsies":[102],"stained":[103],"for":[104,179,293,352,470],"DAPI,":[105],"LAG-3,":[106],"CK,":[107],"TROP2":[109,427],"were":[110,166,234,393],"imaged":[111],"QMiF,":[113],"AI":[116],"quantified":[118],"(figure":[124],"1).":[125],"compared":[127],"continuous":[128],"LAG-3:":[129,299,341],"ratios":[131,455],"between":[132],"responders":[133],"(n=30)":[134],"vs":[135,142],"non-responders":[136,199],"(n=27)":[137],"non-hyperprogressors":[139],"(non-HP,":[140],"n=35)":[141],"hyperprogressors":[143],"(HP,":[144],"n=22)":[145],"defined":[146],"RECIST":[148],"criteria,":[149],"using":[150],"Mann-Whitney":[151],"U":[152],"tests":[153],"Cohen\u2019s":[155,203],"d,":[156],"then":[157],"dichotomized":[158],"at":[159],"65th":[161],"percentile.":[162],"PFS":[163,269,325,353,467],"OS":[165,282],"Kaplan-Meier":[169,468],"univariate":[171,259],"Cox":[172,176,260],"analyses,":[173],"multivariable":[175,290],"models":[177],"adjusted":[178],"age,":[180],"sex,":[181],"BMI,":[182],"ECOG":[183,328],"status,":[184],"ICI":[186,310],"cycle":[187,315],"count.Results":[188],"Responders":[189],"exhibited":[190],"a":[191,212,262,297,348,430,434],"lower":[192,213],"+:":[194],"cell":[196,343,438,454,482],"than":[198,215],"(p":[200,217,237],"<":[201,238,318],"0.001;":[202],"d":[204,220,240],"=":[205,218,221,241,274,287,306],"1.00;":[206],"figure":[207,223,243,278],"2A),":[208],"non-HP":[210],"had":[211,256],"HP":[216],"0.038;":[219],"0.65;":[222],"2B).":[224],"The":[225,437],"distributions":[227],"low-":[230],"high-risk":[232],"groups":[233],"markedly":[235],"distinct":[236],"0.0001;":[239],"2.12;":[242],"2D).":[244],"At":[245],"one":[246],"year,":[247],"85%":[248],"high-ratio":[250],"versus":[251,433,472],"65%":[252],"low-ratio":[254],"progressed.":[257],"analysis,":[261],"high":[263,298,473],"was":[265,330],"associated":[266],"shorter":[268,281,324],"(HR":[270,283,302,312,333],"2.07":[271],"[1.14\u20133.72];":[272],"p":[273,286,305,317],"0.016;":[275],"c-index":[276],"0.59;":[277],"2C)":[279],"1.49":[284],"[0.84\u20132.65];":[285],"0.26).":[288],"analysis":[291],"adjusting":[292],"other":[294],"clinical":[295],"parameters,":[296],"1.90":[303],"[1.02\u20133.73];":[304],"0.045)":[307],"fewer":[309],"cycles":[311],"0.90":[313],"per":[314],"[0.87\u20130.95];":[316],"0.001)":[319],"remained":[320],"independent":[321],"predictors":[322],"while":[326],"status":[329,462],"borderline":[331],"significant":[332],"1.48":[334],"[1.0-2.20];":[335],"p=0.051).Conclusions":[336],"quantification":[338],"QMiF":[346],"represents":[347],"promising":[349],"prognostic":[350],"biomarker":[351],"carcinoma":[357],"inhibitors.":[361],"Given":[362],"modest":[364],"sample":[365],"size":[366],"design,":[369],"these":[370],"findings":[371],"require":[372],"external":[373],"validation":[374],"evaluation":[376],"whether":[378],"this":[379],"marker":[380],"predictive":[382],"benefit":[384],"immunotherapy.Ethics":[386],"Approval":[387],"Ethical":[388],"approval":[389],"informed":[391],"consent":[392],"obtained":[394],"accordance":[396],"Emory":[398],"University":[399],"Cleveland":[401],"clinic":[402],"guidelines":[403],"(STUDY0000535).Abstract":[404],"92":[405,444],"Figure":[406,445],"1QMiF":[407],"whole":[408],"slide":[409],"images":[410],"respective":[412],"ROIs":[413],"showing":[414],"detected":[416],"LAG-3+":[417,451],"(red":[419],"circles)":[420],"model":[423],"alongside":[424],"CK":[425],"staining":[428],"responder":[431],"(A)":[432,459],"non-responder":[435],"(B).":[436],"boundaries":[439],"are":[440],"highlighted":[441],"greenAbstract":[443],"2Panels":[446],"A-B:":[447],"violin":[448],"plots":[449],"response":[457],"group":[458],"hyperprogessor":[461],"(B);":[463],"Panel":[464,475],"C:":[465],"5-year":[466],"curves":[469],"low":[471],"ratio;":[474],"D:":[476],"Violin":[477],"plot":[478],"LAG-3+:":[480],"distribution":[484],"risk":[486]},"counts_by_year":[],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2025-11-05T00:00:00"}